The PhD Programme in Medicines and Pharmaceutical Innovation (i3DU) is a joint initiative of two reference universities in Portugal, the University of Lisbon (ULisboa) and the University of Porto (UPorto), grouping competences and boosting quality in postgraduate training, in cooperation with the pharmaceutical industry. Both universities will award the PhD degrees (accredited by A3ES) that anchor the i3DU Programme.
The consortium involves the Faculties of Pharmacy at ULisboa and UPorto, and the Research Centers iMed.ULisboa at ULisboa, and REQUIMTE and IBMC.INEB at UPorto, in close and effective collaboration with Hovione, Novartis and Sanofi as major industry partners.
The i3DU represents a strong commitment of academia and pharma in Medicines and Pharmaceutical Innovation training that meets well-defined standards for high quality international PhD training and is in line with the preconized research-innovation-education triangle in Europe.
Application period: The call is open from December 6, 2018 to January 14, 2019, 5:00 pm (Lisbon time).
More information: http://www.ff.ul.pt/phd3duul/